These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 3216958)
1. Effects of acute and chronic administration of phencyclidine on the A10 dopaminergic mesolimbic system: electrophysiological and behavioral correlates. French ED Neuropharmacology; 1988 Aug; 27(8):791-8. PubMed ID: 3216958 [TBL] [Abstract][Full Text] [Related]
2. Effects of competitive N-methyl-D-aspartate antagonists on midbrain dopamine neurons: an electrophysiological and behavioral comparison to phencyclidine. French ED; Ferkany J; Abreu M; Levenson S Neuropharmacology; 1991 Oct; 30(10):1039-46. PubMed ID: 1836840 [TBL] [Abstract][Full Text] [Related]
3. Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system. French ED; Pilapil C; Quirion R Eur J Pharmacol; 1985 Oct; 116(1-2):1-9. PubMed ID: 2996909 [TBL] [Abstract][Full Text] [Related]
4. Phencyclidine-induced activation of ventral tegmental A10 dopamine neurons is differentially affected by lesions of the nucleus accumbens and medial prefrontal cortex. Ceci A; French ED Life Sci; 1989; 45(7):637-46. PubMed ID: 2770418 [TBL] [Abstract][Full Text] [Related]
5. MK-801, phencyclidine (PCP), and PCP-like drugs increase burst firing in rat A10 dopamine neurons: comparison to competitive NMDA antagonists. French ED; Mura A; Wang T Synapse; 1993 Feb; 13(2):108-16. PubMed ID: 8446919 [TBL] [Abstract][Full Text] [Related]
6. Behavioral effects of chronic phencyclidine administration in rats. Sturgeon RD; Fessler RG; London SF; Meltzer HY Psychopharmacology (Berl); 1982; 76(1):52-6. PubMed ID: 6805009 [TBL] [Abstract][Full Text] [Related]
7. The role of nucleus accumbens dopamine in the neurochemical and behavioral effects of phencyclidine: a microdialysis and behavioral study. Steinpreis RE; Salamone JD Brain Res; 1993 May; 612(1-2):263-70. PubMed ID: 8330204 [TBL] [Abstract][Full Text] [Related]
8. Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex. Johnson KM; Phillips M; Wang C; Kevetter GA J Neurosci Res; 1998 Jun; 52(6):709-22. PubMed ID: 9669320 [TBL] [Abstract][Full Text] [Related]
9. Mesolimbic and mesocortical dopamine activation induced by phencyclidine: contrasting pattern to striatal response. Deutch AY; Tam SY; Freeman AS; Bowers MB; Roth RH Eur J Pharmacol; 1987 Feb; 134(3):257-64. PubMed ID: 3569414 [TBL] [Abstract][Full Text] [Related]
10. Activation of mesolimbic dopamine function by phencyclidine is enhanced by 5-HT(2C/2B) receptor antagonists: neurochemical and behavioural studies. Hutson PH; Barton CL; Jay M; Blurton P; Burkamp F; Clarkson R; Bristow LJ Neuropharmacology; 2000 Sep; 39(12):2318-28. PubMed ID: 10974315 [TBL] [Abstract][Full Text] [Related]
12. The glycine/NMDA receptor antagonist, R-(+)-HA-966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK-801) in rodents. Bristow LJ; Hutson PH; Thorn L; Tricklebank MD Br J Pharmacol; 1993 Apr; 108(4):1156-63. PubMed ID: 8485625 [TBL] [Abstract][Full Text] [Related]
13. Effects of phencyclidine on ventral tegmental A10 dopamine neurons in the rat. French ED Neuropharmacology; 1986 Mar; 25(3):241-8. PubMed ID: 3703174 [TBL] [Abstract][Full Text] [Related]
14. Acute and chronic phencyclidine effects on locomotor activity, stereotypy and ataxia in rats. Castellani S; Adams PM Eur J Pharmacol; 1981 Jul; 73(2-3):143-54. PubMed ID: 7198045 [TBL] [Abstract][Full Text] [Related]
15. The ontogeny of behavioral sensitization to phencyclidine. Scalzo FM; Holson RR Neurotoxicol Teratol; 1992; 14(1):7-14. PubMed ID: 1593982 [TBL] [Abstract][Full Text] [Related]
16. Effects of phencyclidine on spontaneous and excitatory amino acid-induced activity of ventral tegmental dopamine neurons: an extracellular in vitro study. Wang T; French ED Life Sci; 1993; 53(1):49-56. PubMed ID: 7685848 [TBL] [Abstract][Full Text] [Related]
17. A comparison of the effects of neuroleptics on phencyclidine-induced behaviors in the rat. Sturgeon RD; Fessler RG; London SF; Meltzer HY Eur J Pharmacol; 1981 Nov; 76(1):37-53. PubMed ID: 6119221 [TBL] [Abstract][Full Text] [Related]
18. The role of NMDA and sigma systems in the behavioral effects of phencyclidine in preweanling rats. Scalzo FM; Burge LJ Neurotoxicology; 1994; 15(1):191-200. PubMed ID: 8090359 [TBL] [Abstract][Full Text] [Related]
19. Subchronic phencyclidine administration increases mesolimbic dopaminergic system responsivity and augments stress- and psychostimulant-induced hyperlocomotion. Jentsch JD; Taylor JR; Roth RH Neuropsychopharmacology; 1998 Aug; 19(2):105-13. PubMed ID: 9629564 [TBL] [Abstract][Full Text] [Related]
20. Competitive NMDA receptor antagonists attenuate phencyclidine-induced excitations of A10 dopamine neurons. French ED Eur J Pharmacol; 1992 Jun; 217(1):1-7. PubMed ID: 1397021 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]